Home
/
CVS HEALTH Corp
/
Financials
/
Quarterly
CVS HEALTH Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CVS HEALTH Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$102.87B
Oct 29, 2025
Q2
2025
Jun 30, 2025
$98.92B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$94.59B
May 1, 2025
Q3
2025
Sep 30, 2024
$95.43B
Oct 29, 2025
Q2
2025
Jun 30, 2024
$91.23B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$88.44B
May 1, 2025
Q3
2024
Sep 30, 2023
$89.76B
Nov 6, 2024
Q2
2024
Jun 30, 2023
$88.92B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$85.28B
May 1, 2024
Q3
2023
Sep 30, 2022
$81.16B
Nov 1, 2023
Q2
2023
Jun 30, 2022
$80.64B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$76.83B
May 3, 2023
Q3
2022
Sep 30, 2021
$73.79B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$72.62B
Aug 3, 2022
Q1
2022
Mar 31, 2021
$69.10B
May 4, 2022
Q3
2021
Sep 30, 2020
$67.06B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$65.34B
Aug 4, 2021
Q1
2021
Mar 31, 2020
$66.76B
May 4, 2021
Q3
2020
Sep 30, 2019
$64.81B
Nov 6, 2020
Q2
2020
Jun 30, 2019
$63.43B
Aug 5, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$64.55B
Nov 6, 2019
Q2
2019
Jun 30, 2019
$63.14B
Aug 7, 2019
Q1
2019
Mar 31, 2019
$61.40B
May 1, 2019
Q3
2019
Sep 30, 2018
$47.27B
Nov 6, 2019
Q2
2019
Jun 30, 2018
$46.71B
Aug 7, 2019
Q1
2019
Mar 31, 2018
$45.69B
May 1, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.98B)
Oct 29, 2025
Q2
2025
Jun 30, 2025
$1.02B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$1.78B
May 1, 2025
Q3
2025
Sep 30, 2024
$87.00M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$1.77B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$1.11B
May 1, 2025
Q3
2024
Sep 30, 2023
$2.26B
Nov 6, 2024
Q2
2024
Jun 30, 2023
$1.90B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$2.14B
May 1, 2024
Q3
2023
Sep 30, 2022
($3.41B)
Nov 1, 2023
Q2
2023
Jun 30, 2022
$3.03B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$2.35B
May 3, 2023
Q3
2022
Sep 30, 2021
$1.60B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$2.78B
Aug 3, 2022
Q1
2022
Mar 31, 2021
$2.22B
May 4, 2022
Q3
2021
Sep 30, 2020
$1.22B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$2.98B
Aug 4, 2021
Q1
2021
Mar 31, 2020
$2.01B
May 4, 2021
Q3
2020
Sep 30, 2019
$1.53B
Nov 6, 2020
Q2
2020
Jun 30, 2019
$1.94B
Aug 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.21B)
Oct 29, 2025
Q2
2025
Jun 30, 2025
$2.38B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$3.37B
May 1, 2025
Q3
2025
Sep 30, 2024
$832.00M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$3.05B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$2.27B
May 1, 2025
Q3
2024
Sep 30, 2023
$3.69B
Nov 6, 2024
Q2
2024
Jun 30, 2023
$3.23B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$3.45B
May 1, 2024
Q3
2023
Sep 30, 2022
($3.92B)
Nov 1, 2023
Q2
2023
Jun 30, 2022
$4.67B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$3.55B
May 3, 2023
Q3
2022
Sep 30, 2021
$3.06B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$4.33B
Aug 3, 2022
Q1
2022
Mar 31, 2021
$3.58B
May 4, 2022
Q3
2021
Sep 30, 2020
$3.25B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$4.68B
Aug 4, 2021
Q1
2021
Mar 31, 2020
$3.46B
May 4, 2021
Q3
2020
Sep 30, 2019
$2.93B
Nov 6, 2020
Q2
2020
Jun 30, 2019
$3.33B
Aug 5, 2020